• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥大细胞增多症患者蜂类毒液过敏的流行病学、诊断和治疗。

Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.

机构信息

Department of Allergology, Medical University of Gdansk, Debinki 7, Gdańsk 80-210, Poland.

Allergy Unit, Azienda Ospedaliera Universitaria Integrata of Verona, Piazzale Aristide Stefani 1, 37126, Verona, Italy.

出版信息

Immunol Allergy Clin North Am. 2014 May;34(2):365-81. doi: 10.1016/j.iac.2014.02.004. Epub 2014 Mar 15.

DOI:10.1016/j.iac.2014.02.004
PMID:24745680
Abstract

Hymenoptera venom allergy is a typical IgE-mediated reaction caused by sensitization to 1 or more allergens of the venom, and accounts for 1.5% to 34% of all cases of anaphylaxis. Patients suffering from mastocytosis are more susceptible to the anaphylactic reactions to an insect sting. This article aims to answer the most important clinical questions raised by the diagnosis and treatment of insect venom allergy in mastocytosis patients. Total avoidance of Hymenoptera is not feasible, and there is no preventive pharmacologic treatment available, although venom immunotherapy reduces the risk of subsequent systemic reactions.

摘要

蜂类毒液过敏是一种典型的 IgE 介导的反应,由对毒液中的 1 种或多种过敏原致敏引起,占所有过敏反应的 1.5%至 34%。肥大细胞病患者更易发生昆虫叮咬引起的过敏反应。本文旨在回答肥大细胞病患者昆虫毒液过敏诊断和治疗中提出的最重要的临床问题。完全避免蜂类是不可行的,也没有可用的预防性药物治疗,尽管毒液免疫疗法可降低随后发生全身性反应的风险。

相似文献

1
Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients.肥大细胞增多症患者蜂类毒液过敏的流行病学、诊断和治疗。
Immunol Allergy Clin North Am. 2014 May;34(2):365-81. doi: 10.1016/j.iac.2014.02.004. Epub 2014 Mar 15.
2
Mastocytosis and insect venom allergy.肥大细胞增多症与昆虫毒液过敏。
Curr Opin Allergy Clin Immunol. 2010 Aug;10(4):347-53. doi: 10.1097/ACI.0b013e32833b280c.
3
Hymenoptera venom allergy.膜翅目毒液过敏。
J Dtsch Dermatol Ges. 2010 Feb;8(2):114-27; quiz 128-30. doi: 10.1111/j.1610-0387.2009.07125.x. Epub 2009 Sep 14.
4
Diagnosis of Hymenoptera venom allergy.膜翅目昆虫毒液过敏的诊断
Allergy. 2005 Nov;60(11):1339-49. doi: 10.1111/j.1398-9995.2005.00963.x.
5
Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.蜂毒免疫疗法对膜翅目昆虫毒液过敏患者血清CCL5/RANTES水平的影响。
Immunopharmacol Immunotoxicol. 2015;37(4):375-9. doi: 10.3109/08923973.2015.1063645. Epub 2015 Jul 16.
6
Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.肥大细胞增多症和蜂毒液过敏患者的毒液免疫疗法。
Immunotherapy. 2011 May;3(5):637-51. doi: 10.2217/imt.11.44.
7
Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.未接受免疫治疗的儿童膜翅目毒液过敏的自然病史。
Ann Allergy Asthma Immunol. 2016 Mar;116(3):225-9. doi: 10.1016/j.anai.2015.12.032.
8
Predictors of clinical effectiveness of Hymenoptera venom immunotherapy.膜翅目毒液免疫疗法临床疗效的预测因素。
Clin Exp Allergy. 2014;44(5):736-46. doi: 10.1111/cea.12275.
9
Insect venoms.昆虫毒液
Chem Immunol Allergy. 2010;95:141-156. doi: 10.1159/000315948. Epub 2010 Jun 1.
10
Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?昆虫叮咬过敏反应——肥大细胞增多症?还是其他原因?
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1117-1123. doi: 10.1016/j.jaip.2019.01.014.

引用本文的文献

1
Patients with detectable KIT p.D816V in peripheral blood are at high risk for adverse systemic events during venom immunotherapy and treatment failure.外周血中可检测到KIT p.D816V的患者在毒液免疫治疗期间发生不良全身事件和治疗失败的风险很高。
Clin Transl Allergy. 2025 Jan;15(1):e70019. doi: 10.1002/clt2.70019.
2
Mastocytosis.肥大细胞增多症
Nat Rev Dis Primers. 2025 Apr 24;11(1):30. doi: 10.1038/s41572-025-00611-8.
3
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.肥大细胞增多症中药物和膜翅目毒液超敏反应诊断与管理的挑战
Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123.
4
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.基础类胰蛋白酶正常范围应为 1 至 15ng/ml,涵盖 HαT 健康个体。
J Allergy Clin Immunol Pract. 2023 Oct;11(10):3010-3020. doi: 10.1016/j.jaip.2023.08.008. Epub 2023 Aug 10.
5
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal.肥大细胞疾病的更新诊断标准与分类:一项共识提议。
Hemasphere. 2021 Oct 13;5(11):e646. doi: 10.1097/HS9.0000000000000646. eCollection 2021 Nov.
6
Immunological Responses to Envenomation.对毒液侵袭的免疫反应。
Front Immunol. 2021 May 10;12:661082. doi: 10.3389/fimmu.2021.661082. eCollection 2021.
7
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).肥大细胞增多症患者的COVID-19疫苗接种:欧洲肥大细胞增多症专家网络(ECNM)和美国肥大细胞疾病倡议组织(AIM)的建议
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2139-2144. doi: 10.1016/j.jaip.2021.03.041. Epub 2021 Apr 5.
8
Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.在个性化医学时代诊断、分类和管理肥大细胞激活综合征(MCAS)。
Int J Mol Sci. 2020 Nov 27;21(23):9030. doi: 10.3390/ijms21239030.
9
Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes.膜翅目毒液过敏的精准医学:不同表型和内型的诊断、生物标志物和治疗。
Front Immunol. 2020 Oct 22;11:579409. doi: 10.3389/fimmu.2020.579409. eCollection 2020.
10
Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.肥大细胞增多症的多学科挑战及如何采用个体化医学方法应对。
Int J Mol Sci. 2019 Jun 18;20(12):2976. doi: 10.3390/ijms20122976.